Translate page

Clinical reality in CML is in constant change. Thanks to the hard work and progress of clinicians and researchers worldwide, interesting updates on CML science, diagnostics, treatment and care are regularly presented at international meetings and published in leading peer-reviewed journals.

This section provides you with a selection of scientific publications on CML, relevant news from scientific meetings and expert opinions from leaders in the field. You will also find links to active CML clinical trials.

 Please find below a selection of interesting articles on CML from peer-reviewed journals. Recent publications include:

Clinical Publications:   

  • Expert opinion-management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors
    (Hochhaus A et al. Leukemia, May 2020) (epub ahead of print)
    - open access publication
  • High-risk additional chromosomal abnormalities at low blast counts herald death by CML
    (Hehlmann R et al. Leukemia, May 2020) (epub ahead of print)
    – open access publication
  • Analysis of chronic myeloid leukemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission
    (Machova Polakova K et al. Leukemia, May 2020) (epub ahead of print)
  • Chronic myeloid leukemia prognosis and therapy: Criticisms and perspectives
    (Russo D et al. J Clin Med, June 2020) – open access publication
  • Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
    (Hochhaus A et al. Leukemia, June 2020) (epub ahead of print)
    - open access publication
  • How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment?
    A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA)
    (Breccia M et al. Cancer Med, June 2020) – open access publication

Scientific publications:

  • An integrative model of pathway convergence in genetically heterogenous blast crisis chronic myeloid leukemia
    (Ko TK et al. Blood, June 2020) (epub ahead of print)

Pediatric publications

Click here to see summaries of key CML publications provided to you as a special service by the iCMLf in partnership with Springer Healthcare IME

21st Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
12-15 September, 2019 - Bordeaux, France

24th Congress of the European Hematology Association (EHA)
13-16 June, 2019 - Amsterdam, The Netherlands

Log-in on the EHA Learning Center platform with your EHA login details or create a free account and view CML related

60th Annual Meeting of the American Society of Hematology (ASH)
1-4 December, 2018 - San Diego, USA

This independent educational resource was provided over the last couple of months as a special service by the iCMLf in partnership with Springer Healthcare IME and is supported by a grant from Novartis Oncology.

Stories are based on articles published in international peer-reviewed journals, or conference sessions and written by highly experienced and knowledgeable writers. 

You can access the   CML stories from previous months here